In the early 20th century polio epidemics left many children permanently paralyzed. At that time scientists believed poliovirus could grow only in nerve tissue, so research relied on expensive and ethically problematic monkey experiments. In 1950 Enders, Weller and Robbins showed that the virus could replicate in several kinds of tissue cultures such as embryonic kidney and fibroblast cells, producing clear cytopathic effects. Their work created an inexpensive and reproducible test system, enabling large-scale virus propagation and antibody assays. As a direct consequence, Salk’s inactivated vaccine and Sabin’s oral live vaccine were developed at unprecedented speed. The tissue-culture technique remains a cornerstone of today’s global polio-eradication program.

The trio dissociated multi-layer cultures derived from human and monkey embryos by trypsin treatment and propagated them in serum-supplemented media. Upon inoculation with poliovirus types I–III, clear cytopathic effects appeared within 24–72 hours and could be quantified microscopically. Crucially, viral replication proved independent of cell origin or differentiation status, being observed in kidney, skin, muscle and other tissues. Freeze-thawing of the culture supernatant yielded high-titer virus suspensions suitable for infectivity assays, neutralization tests and serotyping. Switching from animal models to an in-vitro system not only reduced costs and ethical concerns but also provided data more directly translatable to human infection. The method was soon applied to measles, rubella, RSV and many other pathogens, forming the basis of monoclonal antibody screening and viral-vector manufacturing. Insights into temperature, pH and nutrient control in cell culture later informed bioreactor engineering, sustaining the productivity of today’s vaccine industry. Consequently, the work is regarded as a historical turning point linking fundamental virology with public-health practice.

Enders’ protocol combined 0.25 % trypsin dissociation of embryonic tissue with static incubation in DMEM plus 10 % FBS to produce high-density monolayers. Viral inoculation at an MOI of 0.01–0.1 was followed by CPE quantification after 48 h using the Spearman–Karber method to calculate TCID50. The work refuted strict neurotropism, implying that non-neuronal cells possess receptors later identified as CD155. Addition of MgCl2 stabilized virions in the supernatant, informing large-scale production buffers. The culture system proved highly compatible with Salk’s formaldehyde inactivation, preserving over 90 % of antigenic epitopes. Robbins standardized neutralization assays, achieving R² > 0.98 and providing a surveillance benchmark. The multi-tissue culture method became the core of WHO SOPs and is still used in Global Polio Eradication Initiative labs. The expanded host-cell concept was adapted to coronavirus and Zika reverse-genetics platforms, enabling rapid pandemic responses. Innovative statistics such as F-tests assessed reproducibility of cryopreserved cell stocks. Overall, the study prefigured cell-based vaccine manufacture, seed-lot systems and GMP, underpinning today’s biopharmaceutical industry.